Duloxetine Versus Placebo for the Treatment of North American Women With Stress Urinary Incontinence

Abstract

These phase 3 data are consistent with phase 2 data and they provide further evidence for the safety and efficacy of duloxetine as a pharmacological agent for the treatment of women with SUI.